Bone Therapeutics

A ULB spin-off created in 2006, BoneTherapeutics specialises in using cell therapy to treat joint and bone disease. The company develops innovative cell products used in the reconstruction and regeneration of bone tissue, using technology that makes osteoblasts from adult stem cells.

Its competitive advantage and positioning in the bone disease cell therapy sector are rooted in:

  • ioneering work in stem cell transplants carried out by the scientists who founded the company,

  • an excellent knowledge of bone diseases and their pathophysiology,

  • unparalleled clinical and technical skills.

Bonetherapeutics clinical programmes include phase ll and phase lll clinical studies for the treatment of rare bone diseases, as well as for unknitted fractures. The company also boasts several preclinical programmes, as well as an allogenic programme and a program for matrices of cell products. The company was created by pharmaceutical and hospital professionals. They brought together an in-depth knowledge of stem cells and the associated production processes, unrivalled expertise in cell therapy, and significant Corporate and Business Development Experience.

BoneTherapeutics works in close partnership with Erasme Hospital (ULB, Brussels), and Sart Tilman University Hospital (ULg, Liège).

Rue Adrienne Bolland 8,
B-6041 Gosselies.
T. +32 (0)2 529 59 90
F. +32 (0)2 529 59 93